Objectives: To examine the in situ distributions of vitamin D receptors (VDR) and matrix metalloproteinases (MMPs) in osteoarthritic cartilage for comparison with non-arthritic, normal cartilage; and to assess the in vitro effects of 1 ,25 dihydroxyvitaminD 3 (1 ,25(OH) 2 D 3 ) on MMPs-1, -3 and -9 and prostaglandin E 2 (PGE 2 ) production by cultures of human articular chondrocytes (HAC) shown to be VDR-positive.
Introduction
Osteoarthritis (OA) is the major cause of disability in the elderly yet little is known about its aetiopathogenesis 1 . Early changes in osteoarthritic cartilage include fraying of the superficial articular surface, the appearance of fibrillations and loss of cartilage proteoglycan (PG), each of which becomes more prominent as the disease progresses, along with the noticeable proliferation of chondrocytes into clusters or 'clones' 2 . Chondrolytic matrix metalloproteinases (MMPs) are known to be important in osteoarthritic cartilage degradation 3 where the focal expression of mRNA for different MMPs by chondrocytes has been reported 4 . Cytokines have been implicated in the complex regulation of MMP production by chondrocytes 5 , and recent animal studies have demonstrated a contributory role for vitamin D3 in cartilage metabolism [6] [7] [8] . The biologically active metabolite of vitamin D, 1 ,25dihydroxyvitaminD 3 , (1 ,25(OH) 2 D 3 ), has a recognized role in calcium and phosphorus metabolism and in a variety of bone and mineral disorders such as osteoporosis and rickets 9 . 1 ,25(OH) 2 D 3 has other biological functions including the regulation of cell proliferation, differentiation and immune function 10 brought about by its binding to vitamin D receptors (VDR) that are expressed by a variety of cell types such as monocytes, fibroblasts, activated lymphocytes, various myeloid cells and also chondrocytes 10, 11 . 1 ,25(OH) 2 D 3 is purported to modulate chondrocyte behavior within different zones of the growth plate cartilage 8, 12 and has different effects on proteoglycan and collagen synthesis, plasminogen activator expression and the regulation of matrix metalloproteinase production 12, 13 . However, most information to date relates to animal models or chondrocyte cultures derived from rat or rabbit cartilage.
The recent demonstration of 1 ,25(OH) 2 D 3 synthesis by macrophages derived from the synovial fluid of patients with inflammatory arthritis 14, 15 , and the report that chondrocytes express VDR 11 have suggested a contributory role for 1 ,25(OH) 2 D 3 in the aberrant behavior of chondrocytes in OA. The present study has assessed the nature and extent of VDR expression in osteoarthritic cartilage together with the distributions of MMPs-1, -3 and -9 in situ. In addition, we have examined the effects of 1 ,25(OH) 2 D 3 on MMP production by human articular chondrocytes in vitro, especially after activation by tumor necrosis factor-(TNF-) and phorbol myristate acetate (PMA). Further, since prostaglandin E 2 (PGE 2 ) is known to contribute to bone remodeling/resorption and may modulate MMP expression 16, 17 , the effects of 1 ,25(OH) 2 D 3 on PGE 2 production by stimulated or 'activated' HAC has also been examined.
Methods

TISSUE SPECIMENS
Osteoarthritic knee tissues, from 30 different patients, were removed at joint replacement surgery and transferred to the laboratory in Hanks balanced salt solution (HBSS) where cartilage was sampled from one tibial plateau of each specimen within 60 min of operation. Similar agematched, macroscopically normal cartilage samples were obtained from six early autopsy cases. Cartilage tissues were sampled down to the subchondral bone, fixed in Carnoy's fixative for 2 h at 20°C, dehydrated in alcohol and processed to paraffin wax. 5 m cartilage tissue sections from the different specimens were stained with acidified toluidine blue to determine histological grading. Each specimen was examined by two independent assessors and graded as 0, 1, 2 or 3, defined in Table I and adapted from previous studies of clinical grading 4, 18 . Sixteen specimens were selected for an immunological study of VDR and MMP distributions; these comprised 11 osteoarthritic cartilage samples representing grades 1, 2, 3, and five non-arthritic normal cartilage samples, grade 0. Two cartilage zones were identified, viz. a 'superficial zone' beneath the articular surface and a 'deep zone' as previously defined and illustrated 2, 4 . The minimum number of cells examined in any zone was 40 (range 40-225, mean value 95). All cartilage specimens were derived from individuals in the age range 47-76 years (mean 68). 5 m sections were cut and consecutive sections were immunostained for VDR, MMP-1, MMP-3 and MMP-9, respectively.
IMMUNOLOCALIZATION OF VDR
Tissue sections were pre-treated with 2M HCl at 37°C for 30 min, an antigen retrieval procedure recommended by the supplier of the primary antibody. Non-immune rabbit serum at 10% (v/v) in Tris-buffered saline (TBS) was applied to the tissue sections for 20 min at 20°C. Rat monoclonal antibody to chick VDR (known to cross-react with human VDR; Cambridge BioScience, U.K.) was applied for 2 h at 20°C after dilution to 5 g/ml in TBS. After 3×10 min washes in TBS, biotinylated rabbit antirat IgG (DAKO Ltd, Cambridge, U.K.) diluted 1:200 in TBS was applied to the sections for 45 min at 20°C. After further washing in TBS, alkaline phosphatase (AP) conjugated ABC (Avidin-Biotin Complex system, DAKO) was applied to the sections for 45 min at 20°C. After further washing in TBS the AP was developed using new fuchsin substrate to give a red color. Sections were lightly counterstained with toluidine blue before dehydrating and mounting in Histomount permanent mountant (National Diagnostics, Hull, U.K.).
IMMUNOLOCALIZATION OF MATRIX METALLOPROTEINASES -1, -3,
AND -9
Tissue sections were first incubated for 30 min with 10% (v/v) donkey serum. Sheep polyclonal antibodies to MMPs-1, -3 and -9 (Biogenesis, Poole, U.K.) were diluted 1:300, 1:500 and 1:250, respectively, in TBS and applied to the sections for 2 h at 20°C followed by 3×10 min washes The S-100 protein is a recognized marker for human articular chondrocytes 19 and its antibody was shown to effectively access the chondrocytes of normal cartilage. Tissue sections were first incubated for 30 min with 10% (v/v) swine serum. Rabbit polyclonal antibody to S-100 protein (Dako, U.K.) was diluted 1:100 in TBS and applied to the sections for 2 h at 20°C followed by 3×10 min washes in TBS. Biotinylated swine antirabbit IgG (Dako, U.K.) was diluted 1:300 in TBS and applied to the sections for 45 min at 20°C. After further washing AP-conjugated ABC was applied and developed as described above. Sections were lightly counterstained in toluidine blue.
DUAL IMMUNOLOCALIZATION OF VDR AND MMP-3
Tissue sections were pretreated with rabbit serum 10% (v/v) for 30 min after which primary antibodies to VDR and MMP-3, diluted in TBS as described above were applied together at 4°C overnight. The sections were washed 3×10 min in TBS followed by incubation with a combination of biotinylated rabbit antirat IgG and horseradish peroxidase (HRP)-conjugated rabbit anti-sheep IgG for 1 h at 20°C. Following a further 3×10 min washes inTBS the sections were incubated with AP-conjugated ABC complex as described above for 45 min at 20°C. After further washing the HRP was developed first using 3-amino-9-ethylcarbazole (AEC; Sigma, U.K.) to give a red color, followed by development of the AP using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT; Sigma, U.K.) to give a blue-black color. Sections were mounted in Immunomount aqueous mountant (Shandon, U.K.).
IMMUNOHISTOCHEMISTRY CONTROLS
For controls the primary antibody was replaced by the appropriate non-immune rat or sheep IgGs at concentrations corresponding to those of the primary antibodies. Immunoadsorption of each antibody with its relevant purified antigen subsequently produced negative observations, as described previously 20, 21 .
CELL CULTURES
Human articular cartilage from OA specimens was enzymically digested to provide chondrocyte cultures as previously described 22 . Primary chondrocyte cultures grown to confluence in Dulbecco's Modified Eagle's Medium (DMEM)+10% (v/v) fetal calf serum (FCS), were harvested and seeded into 12-well culture dishes (Nunc, Gibco, U.K. ). Chondrocytes were also grown on glass coverslips in DMEM+2% FCS and at various stages of confluence the cells were briefly fixed in Carnoy's fixative and immunostained for VDR and S-100 as described for the cartilage tissue sections. Cells were also immunostained for type II cartilage collagen using rabbit polyclonal antibody (Chemicon, Harrow, U.K.), diluted 1:20 and visualized with the ABC detection system as described.
ENZYME LINKED IMMUNOSORBENT ASSAYS (ELISA)
ELISA methodology was used to determine protein levels of MMP-1 (collagenase 1, sensitivity: 0.8-50 ng/ml), MMP-3 (stromelysin, sensitivity: 0.4-25 ng/ml) and MMP-9 (gelatinase B, sensitivity: 1.5-100 ng/ml) as previously described 23 . PGE 2 was measured using a competitive binding assay kit purchased from R & D Systems Europe Ltd, Abingdon, U.K., with a sensitivity range of 39-5000 pg/ ml. All ELISA results were calculated as ng or pg antigen/ml culture medium/10 6 cells/48 h.
Results
IMMUNOHISTOCHEMISTRY
All eleven specimens of osteoarthritic cartilage showed chondrocytes positive for the vitamin D receptor [ Fig.  1(a),(b) ], in contrast to the infrequent expression shown by the control non-arthritic specimens [ Fig. 1(c) ]. The proportion of VDR + cells in osteoarthritic cartilage was variable, not only between specimens but also within the different zones of a single specimen (Table I ). The two zones described as the 'superficial' or 'deep' zone have been reported by other studies 2, 4, 24 . We recognize that the original 'superficial' zone of grade 1 lesions has mainly been lost on progression to grade 3 and will not represent the same tissue location as described for the non-arthritic control cartilage specimens. We therefore use the term 'superficial' to describe the location at and just beneath the articular surface of each specimen irrespective of the grading, thereby allowing a comparative assessment for VDR and the three MMPs (Table I ). The most prominent VDR + staining of chondrocytes occurred within the superficial zone of Grades 1 and 3 (Table I) . Although some chondrocytes were observed to be VDR + within the deep zones their numbers were consistently less than in the superficial zone. However, the deep zone of grade 3 osteoarthritic cartilage usually contained markedly more VDR+ cells than those for Grades 1 and 2. VDR expression was observed for both single chondrocytes [ Fig. 1(a) ] and those found in typical OA chondrocyte clusters [ Fig.  1(b) ], but seldom in the specimens of normal articular cartilage.
The extent of immunostaining for MMPs -1, -3 and -9 was variable in the osteoarthritic cartilage specimens [ Fig.  1(d-f) ]. MMP-1 was most prominent in Grade 3 superficial zone cartilage, with the deep zone of Grades 1 and 2 Fig. 1(d) ]. MMP-3 was most prominent in the superficial zone of Grades 2 and 3 with markedly less staining in the deep zone [ Fig. 1(e) ], whereas MMP-9 immunostaining was less prevalent than that for MMPs -1 and -3 [ Fig. 1(f) and Table I] . By contrast normal, non-arthritic cartilage revealed negligible immunostaining for MMP-1 [ Fig. 1(g) ]. Control tissue sections for the immunostaining of VDR and MMPs consistently gave negative results [ Fig. 1(h) and (i) , respectively]. The S-100 antibody effectively stained most chondrocytes in normal cartilage thereby demonstrating that the weak immunostaining of these specimens was not due to lack of penetration of antibodies (Fig. 2) . Table I summarizes the immunohistochemical results obtained for VDR and each of the three MMPs; all four antigens were significantly elevated in the osteoarthritic compared with non-arthritic specimens, and especially so for VDR. Whereas significant differences were observed between the two cartilage zones for the extent of VDR and MMP immunostaining, in general Grade 3 was greater than 2 and 1, and the superficial zone was greater than the deep zone (see legend to Table I (Fig. 2) , this decreased as the cells approached confluence (Fig. 2) . Thus to determine the effects of 1 ,25(OH) 2 D 3 on MMP and PGE 2 production the chondrocytes were used at sub-confluence to ensure VDR expression by a major proportion of the cells. No noticeable differences in VDR + immunostaining was observed following TNF -and PMA-stimulation of the HAC cultures compared to controls, and all three preparations of OA derived HAC were shown to be VDR + at sub-confluence. In addition, to confirm the chondrocytic phenotype of these cultures, the cells were stained for both S-100 and type II cartilage collagen, demonstrating the continued expression of both antigens (Fig. 2) .
Osteoarthritis and
The data in Fig. 3 represents the mean values from experiments made with sub-confluent HAC from three different specimens in which the responses to the treatments were qualitatively similar. 1 ,25(OH) 2 D 3 alone had little effect on MMP-1, -9 or PGE 2 production, but when added to cells stimulated with TNF or PMA more marked responses were observed (Fig. 3) . 1 ,25(OH) 2 D 3 had no significant effect on TNF -stimulated MMP-1 production by HAC, but when stimulated with PMA the resultant increase in MMP-1 was significantly increased by the addition of 1 ,25(OH) 2 D 3 ( Fig. 3(a) ). By contrast, MMP-3 production by HAC was increased by 1 ,25(OH) 2 D 3 treatment alone, and its addition to TNF or PMA-stimulated cells significantly enhanced MMP-3 production [ Fig. 3(b) ]. MMP-9 was not produced by the HAC with or without 1 ,25(OH) 2 D 3 or TNF exposure. However, PMA stimulation significantly increased MMP-9 production, this being reduced by approximately 75% by the simultaneous addition of 1 ,25(OH) 2 D 3 [ Fig. 3(c) ].
1 ,25(OH) 2 D 3 had no effect on control values of PGE 2 production by HAC in vitro, and TNF also showed only a marginal increase. However, PMA stimulation of chondrocytes resulted in more than a five-fold increase in PGE 2 production, this being reduced by more than 60% by the concomitant addition of 1 ,25(OH) 2 D 3 (Fig. 4) .
Discussion
This study has demonstrated VDR expression by chondrocytes within osteoarthritic cartilage, particularly near to the articular surface and fibrillations, an observation in contrast with normal cartilage specimens where VDR + cells were rarely observed. This up-regulation of VDR + in osteoarthritic cartilage, an observation which was mirrored in the cartilage derived from rheumatoid joints 11 , supports the idea that 1 ,25(OH) 2 D 3 may play a regulatory role in the modulation of chondrocyte behavior in these pathologies 23, 25 . Recent studies have reported 1 ,25(OH) 2 D 3 synthesis by synovial fluid macrophages from patients with inflammatory arthritis 15 , and that the receptor:metabolite complex interacts with nuclear DNA to evoke a cellular response 26, 27 . Thus the marked nuclear staining observed for some osteoarthritic cartilage specimens might well suggest local activation of VDR + chondrocytes. The extent of VDR expression was variable between specimens, but as yet the factors responsible for its regulation remain unclear. Although a noticeable down-regulation of VDR in chondrocytes approaching confluence in culture was noted, little difference was observed for VDR expression in situ between single chondrocytes and those in clusters; most VDR + differences being noted between the deep and superficial zones of the same cartilage specimen.
The importance of MMPs in the pathophysiology of OA is well established, both at protein and mRNA level 4, 28, 29 . Collagenase 1 (MMP-1),collagenase 3 (MMP-13) and stromelysin 1 (MMP-3) have all been demonstrated both intra-and extracellularly in localized sites within osteoarthritic cartilage 28, 29 . In this study MMPs -1, -3 and -9 were demonstrated in cartilage sites where a proportion of the chondrocytes were VDR + ; an association which suggested the possibility that 1 ,25(OH) 2 D 3 could be involved in the regulation of MMP and cytokine production at sites of cartilage degradation in OA. Such a proposal could be considered fortuitous and unrelated. However, the dual localization study showing that some VDR + cells were also expressing MMP-3 suggests otherwise, this being supported to some extent by the in vitro studies where 1 ,25(OH) 2 D 3 was shown to directly modulate MMP-3 production by HAC. For the in vitro chondrocyte studies it was important to use VDR + chondrocytes; thus the demonstration that sub-confluent chondrocytes appeared to be more positive than confluent cells was the prime reason for using the former in the MMP and PGE 2 experiments.
Previous studies regarding a relationship between 1 ,25(OH) 2 30 demonstrated the discoordinate regulation of MMP-1 and -9 production by human mononuclear phagocytes. A plenitude of agents are known to have regulatory effects on MMP expression. The cytokines IL-1 and TNF , and the prostanoids, such as PGE 2 , have all been implicated in the enhanced production of specific MMPs. The increased levels of MMP-1, -3 and -9 produced by IL-1 -stimulated chondrocytes in vitro was further enhanced upon addition of 1 ,25(OH) 2 D 3 23 , an observation in accord with the TNF and PMA-induced increase for MMP-1 and MMP-3 reported here. By contrast, the PMA-induced increase in MMP-9 and PGE 2 production by the same chondrocytes was suppressed by exposure to 1 ,25(OH) 2 D 3 , thereby indicating both enhancing and suppressive roles for the vitamin D metabolite in the regulation of these four chondrocyte products. Such disparate modulatory effects of 1 ,25(OH) 2 D 3 on 'activated' chondrocytes may be of relevance to the chondrolytic processes which potentiate intrinsic cartilage damage.
1 ,25(OH) 2 D 3 appears to have multifunctional properties which relate to specific cell types. 1 ,25(OH) 2 D 3 has different effects on cytokine production and some inflammatory responses. For example, 1 ,25(OH) 2 D 3 acts synergistically with bone matrix components to stimulate IL-1 production by mononuclear cells 31 , inhibits IL-1 production by myeloid cells 32 , and can regulate IL-1 production by rat chondrocytes 8 . It seems plausible, therefore, that IL-1 and TNF production by OA chondrocytes might be affected by 1 ,25(OH) 2 D 3 , but this has yet to be examined.
Prostaglandins are primary mediators in inflammation, are recognized as having prominent roles in the immune response, and PGE 2 has been implicated in the potentiation of MMP production in some cell cultures 17 . 1 ,25(OH) 2 D 3 was reported to stimulate PGE 2 production by rat growth zone chondrocytes 33 , but in the present study 1 ,25(OH) 2 D 3 had little effect on basal production of PGE 2 by human chondrocytes. However, the enhanced PGE 2 production observed following chondrocyte stimulation with PMA was markedly suppressed by the simultaneous addition of 1 ,25(OH) 2 D 3 .
In summary, our in vitro data suggest that 1 ,25(OH) 2 D 3 has more pronounced effects on chondrocytes in states of activation or proliferation, where it appears to modulate MMP and PGE 2 production. Whether 'activated' chondrocytes manifest increased VDR expression remains uncertain at present, as does the nature of its regulation. Although 1 ,25(OH) 2 D 3 has the potential to modify MMP-1, MMP-3, MMP-9 and PGE 2 production by activated chondrocytes in vitro, these represent only a minority of the proteinases, prostanoids and cytokines elaborated by such cells. Further studies are needed to examine the immunomodulatory effects of this vitamin D metabolite on the various chondrolytic or reparative processes of relevance to the degenerative changes within osteoarthritic cartilage.
